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Abstract
Dr. Pedro Cahn, International AIDS Society (IAS) President and Mr. Craig McClure, IAS Executive
Director, provide their thoughts and analysis on the current and future role of the IAS as part of
the global response to HIV/AIDS.
Commentary
In 1981 the first indication of a disturbing new illness that
defied medical classification appeared in the Center for
Disease Control and Prevention's Morbidity and Mortal-
ity Weekly Report [1]. Little could have prepared the sci-
entific community – or the world – for the human
catastrophe that followed. We are now just past the
twenty-five year mark in the history of this epidemic and
yet, despite impressive scientific advances in both diagno-
sis and treatment, it is continuing to outpace our efforts to
contain it. This year marked a number of anniversaries in
our history with this epidemic, including 10 years since
the advent of highly active antiretroviral therapy
(HAART), so it is a useful point at which to reflect on our
progress with this disease and to chart a way through the
difficult terrain ahead.
As the world's leading independent association of profes-
sionals working in HIV, the International AIDS Society
(IAS) has a unique role to play as part of the global
response to this epidemic in the decades to come. With
over 10,000 members from 171 countries, the IAS repre-
sents individuals working at every level of the response,
from scientists and clinicians to policymakers and com-
munity educators. The IAS was established as a non-profit
organization in 1988, with a mandate to organize the
biennial International AIDS Conferences, although the
Stockholm-based staff remained small and responsibility
for organizing the conferences was primarily undertaken
by professional conference organizers. That changed in
2004, when the Governing Council of the IAS decided to
upgrade its structure by strengthening the professional
staff at the secretariat and moving the headquarters to
Geneva, Switzerland. The move was intended to
strengthen links with other health NGOs and UN multi-
lateral agencies. Since then the IAS secretariat has grown
to a professional staff of 30, and the Governing Council
has established an ambitious agenda of work for the
organization over the coming years, outlined in Stronger
Together: Strategic Framework 2005 – 2009, available on
the IAS website [2].
An initial priority for the IAS in 2005 was to undertake a
comprehensive review of the International AIDS Confer-
ence, which had evolved from a small medical meeting in
Atlanta in 1984 to a massive, multisectoral health confer-
ence attended by over 15,000 participants in Bangkok in
2004, and over 20,000 in Toronto in 2006. The IAS con-
sulted broadly with stakeholders on how to maximize the
reach and impact of the conference. The IAS received
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input through group consultations, confidential inter-
views, internet fora, and other meetings. The recommen-
dations from those consultations – among others, to
improve the quality of science, to broaden diversity, to
facilitate cross-disciplinary linkages and dialogue, and to
strengthen the focus on youth – began to be implemented
in the planning for the XVI International AIDS Conference
(AIDS 2006) in Toronto and will be implemented more
fully in planning for the XVII International AIDS Confer-
ence (AIDS 2008) in Mexico City. The report from the
Future Directions project, including detailed recommen-
dations, is available on the IAS website. We are also
strengthening the conference's role as an accountability
mechanism, a focus reflected in the conference theme of
AIDS 2006, Time to Deliver, that has implications across
disciplines and the three programme areas of science,
community and leadership.
In addition to the large international conferences, the IAS
also organizes the biennial Pathogenesis, Treatment and
Prevention conference, which will be held next in Sydney,
Australia, 22–25 July 2007. This is the premier open,
international scientific meeting on HIV, and was recently
expanded to recognize and encourage the importance of
biomedical prevention research. It provides researchers
and clinicians with opportunities to hear and discuss the
latest advances in HIV research across the three major sci-
entific tracks (basic science, clinical science and biomedi-
cal prevention science), and to address how advances in
research can be rapidly applied to practice. The IAS is com-
mitted to continuously improving the conferences and
strengthening their role beyond three or five-day events to
become part of an ongoing cycle of education, network-
ing, promotion of best practice and advocacy in the fight
against HIV/AIDS.
The IAS is also strengthening its commitment to regional
development, expanding our involvement in three main
areas: collaboration with regional societies, engagement
with regional conferences, and supporting and expanding
IAS membership in each region. The IAS was a co-organ-
izer of the first Eastern European and Central Asian Con-
ference on AIDS (EECAAC), held 14 – 17 May 2006 in
Moscow, and has also provided technical support and
advice to other regional conferences including the African
regional meeting in Abuja, Nigeria last year. Of course,
there is no "one size fits all" approach to regional activi-
ties. The unique characteristics of each region require that
we build strong relations with key players in each region,
learn all we can about the particular issues facing HIV pro-
fessionals there and tailor our activities to meet the needs
and requests for collaboration that we receive.
In addition to its conferences and regional development
activities, the IAS coordinates several initiatives. The IAS
Industry Liaison Forum is a unique initiative designed to
accelerate scientifically promising, ethical research in
resource-limited settings, with a particularly focus on the
role and responsibility of industry as sponsors and sup-
porters of research. ILF supports dialogue between the
pharmaceutical industry, independent investigators and
major contributors to research investment such as the Bill
& Melinda Gates Foundation. The IAS, under both the ILF
and our work with the Bill & Melinda Gates Foundation,
has become a significant force in placing pre-exposure
prevention prophylaxis (PREP) research on the agenda of
policymakers and opinion-leaders. The IAS also co-pub-
lishes the electronic Journal of the International AIDS
Society (eJIAS) with Medscape General Medicine, a peer-
reviewed, open-access scientific journal aimed at publish-
ing research focused on the developing world. Under the
leadership of Editor Mark Wainberg (who was recently
joined by Ugandan clinician Dr. Elly Katabira as Co-Edi-
tor), the volume of submissions to this journal has grown
rapidly since its launch in July 2004. It is fully indexed on
PubMed and available online [3]. The IAS is also increas-
ingly involved in the development and delivery of a range
of education and training programmes designed to help
individuals working in HIV advance professionally, from
administering the HIV Research Trust Training Scholar-
ships, funded through revenues generated by the Interna-
tional Congress on Drug Therapy in HIV Infection, held
biennially in Glasgow, to the development of an IAS Edu-
cation Programme for IAS 2007. Providing education and
training opportunities for its membership is important for
any professional society, and the IAS is looking at ways to
strategically expand its role in this area in order to
strengthen the capacity of the HIV workforce.
The IAS has been increasingly involved in policy and
advocacy debates over the past two years. We have advo-
cated strongly for the availability of methadone and
buprenorphine in Eastern Europe and Central Asia, where
injecting drug use is fuelling that epidemic; on the need
for greater political accountability on setting and meeting
treatment and prevention targets through the UNGASS
process; on increased investment to train, hire and sustain
human resources required for scaling up prevention, treat-
ment and care programmes in the developing world. A
detailed policy and advocacy strategy, currently in devel-
opment, will ensure the IAS is an effective advocate for its
membership, bringing its voice and influence on key pol-
icy issues, in collaboration with other stakeholders
engaged in the response to HIV/AIDS.
The role of the IAS as a global knowledge-broker, a facili-
tator of dialogue, and an independent voice on key HIV/
AIDS policy and advocacy issues will strengthen as we
move forward in our work in the coming years; the expan-
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among clinicians and the scientific community requires
careful planning in how we develop and deliver training,
professional development and networking opportunities
to meet the challenges of the coming decades.
The IAS has a unique opportunity – and responsibility –
to bring together individuals working in diverse settings
and disciplines, from areas of the world separated by
geography, culture, language and resources, and to lever-
age the expertise and knowledge of its members in an
effective, sustained global response. If there is a lesson to
be learned from our history with this disease, it is that we
can do far more collectively than we can individually. As
the IAS embarks on an ambitious new phase in its devel-
opment, we are looking forward to strengthening our
engagement with the scientific community, while we
build new partnership with NGOs, activists and others
working on the frontlines of the response. The IAS encour-
ages all professionals working in the HIV/AIDS field to
become members. We are convinced that in the struggle
against this epidemic we will be stronger together.
Pedro Cahn, IAS President
Craig McClure, IAS Executive Director
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